Direct Thrombin Inhibitor [EPC]

1052 reported adverse events

Drugs of this class: ARGATROBAN

These side effects are most commonly reported by patients taking drugs of the Direct Thrombin Inhibitor [EPC] class:

# Side effect Count
0 HEPARIN-INDUCED THROMBOCYTOPENIA 116
1 INTERNATIONAL NORMALISED RATIO INCREASED 108
2 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 81
3 COAGULATION TIME PROLONGED 64
4 HAEMORRHAGE 63
5 CEREBRAL INFARCTION 50
6 PULMONARY EMBOLISM 48
7 DEEP VEIN THROMBOSIS 47
8 THROMBOCYTOPENIA 46
9 THROMBOSIS 45
See all common reactions for Direct Thrombin Inhibitor [EPC]

Drugs of the Direct Thrombin Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BURKITT'S LYMPHOMA STAGE IV 1 0.2500
1 OESOPHAGEAL INTRAMURAL HAEMATOMA 7 0.1795
2 BILE OUTPUT 1 0.1250
3 GRANULICATELLA BACTERAEMIA 1 0.1111
4 FAECAL CALPROTECTIN DECREASED 1 0.0833
5 GASTRIC LAVAGE ABNORMAL 1 0.0588
6 COAGULATION TIME PROLONGED 64 0.0543
7 INFECTIVE AORTITIS 1 0.0435
8 ACTIVATED PARTIAL THROMBOPLASTIN TIME ABNORMAL 8 0.0421
9 CARDIOPULMONARY BYPASS 1 0.0417
See all enriched reactions for Direct Thrombin Inhibitor [EPC]